300,000 IU of Vitamin D is not enough during pregnancy – RCT May 2018

Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial

The Journal of Clinical Endocrinology & Metabolism, jc.2018-00109, https://doi.org/10.1210/jc.2018-00109
Maryam Rostami, PhD Fahimeh Ramezani Tehrani, MD Masoumeh Simbar, PhD Razieh Bidhendi Yarandi, MS Sonia Minooee, MS Bruce W Hollis, PhD Farhad Hosseinpanah, MD

VitaminDWiki
  • 8 dosing branches this pregnancy RCT from Iran
  • Many of the branches included 50,000 IU of vitamin D during pregnancy
  • 50,000 IU weekly for 6 weeks or 300,000 IU injection resulted half getting> 20 ng, which other studies have found does not provide much benefit
  • However, all of the supplementation branches greatly reduced miscarriage rate

See also VitaminDWiki

Pregnancy trials getting most women above 40 ng used a total of > 1,300,000 IU (not just 300,000 IU total)
(6,400 IU/day for 30 weeks)
Healthy pregnancies need lots of vitamin D has the following summary

Problem
Vit. D
Reduces
Evidence
0. Chance of not conceiving3.4 times Observe
1. Miscarriage 2.5 times Observe
2. Pre-eclampsia 3.6 timesRCT
3. Gestational Diabetes 3 times RCT
4. Good 2nd trimester sleep quality 3.5 times Observe
5. Premature birth 2 times RCT
6. C-section - unplanned 1.6 timesObserve
     Stillbirth - OMEGA-3 4 timesRCT - Omega-3
7. Depression AFTER pregnancy 1.4 times RCT
8. Small for Gestational Age 1.6 times meta-analysis
9. Infant height, weight, head size
     within normal limits
RCT
10. Childhood Wheezing 1.3 times RCT
11. Additional child is Autistic 4 times Intervention
12.Young adult Multiple Sclerosis 1.9 timesObserve
13. Preeclampsia in young adult 3.5 timesRCT
14. Good motor skills @ age 31.4 times Observe
15. Childhood Mite allergy 5 times RCT
16. Childhood Respiratory Tract visits 2.5 times RCT

RCT = Randomized Controlled Trial
Editorial on this study Call to action – more Vitamin D for pregnancies, loading doses are OK – Holick Aug 2019

PDF is available free at Sci-Hub   10.1210/jc.2018-00109

Objective
We aimed at determining the effectiveness of a prenatal screening program on optimizing 25-hydroxyvitamin D(25(OH)D) levels and preventing pregnancy complications. Also, to identify a safe regimen, we compared several regimens in a subgroup of vitamin D deficient pregnant women.

Design: Two cities of Masjed-Soleyman and Shushtar from Khuzestan province, Iran were selected as the screening and non-screening arms, respectively. Within the screening arm, a randomized controlled trial was conducted on 800 pregnant women.

Setting: Health centers of Masjed-Soleyman and Shushtar cities

Patients or Participants: Pregnant women aged 18-40 years

Intervention: Women with moderate(25(OH)D:10-20ng/ml) and severe(25(OH)D<10ng/ml) deficiency were randomly divided into 4 subgroups and received D3 until delivery.

Main Outcome Measure: Maternal concentration of 25(OH)D at delivery and rate of pregnancy complications

Results
After supplementation, only 2% of the women in the non-screening site met the sufficiency level(>20ng/ml), versus 53% of the women in the screening site. Adverse pregnancy outcomes including pre-eclampsia, gestational diabetes mellitus and preterm delivery were decreased by 60,50 and 40% in the screening site. A D3 injection in addition to monthly 50,000IU maintenance therapy contributed the most to achievement of sufficient levels at delivery.

Conclusions
Prenatal vitamin D screening and treatment program is an effective approach in detecting deficient women, improving 25(OH)D levels and decreasing pregnancy adverse outcomes.

3969 visitors, last modified 25 Jun, 2019,
Printer Friendly Follow this page for updates